Diaverum is a leading global provider of life enhancing renal care to patients with Chronic Kidney Disease (CKD). With over 11,000 employees worldwide, caring for circa. 39,000 patients, offering 6 million treatments annually and running more than 421 clinics in 22 countries.
Headquartered in Sweden, Diaverum’s main focus is on haemodialysis, in conjunction with a portfolio of treatments ranging from preventive care, peritoneal dialysis and home care to co-ordination of patients’ comorbidities and transplantation services. CKD is seen as a global and escalating challenge today affecting about 10% of the world’s adult population. It’s primarily caused by lifestyle diseases such as diabetes, and the prevalence is increasing in particular in developing countries.
The company operates in a sizeable and growing market with robust industry fundamentals, where the number of patients requiring kidney care is growing due to changes in the population dynamics and lifestyles.
To learn more about the company, click here.